Scarica l'app Stockscreener
7.3677
2.67%
-0.2023
Precedente Chiudi:
$7.57
Aprire:
$7.19
Volume 24 ore:
65,311
Relative Volume:
0.15
Capitalizzazione di mercato:
$471.59M
Reddito:
$198.53M
Utile/perdita netta:
$-63.68M
Rapporto P/E:
-7.2077
EPS:
-1.0222
Flusso di cassa netto:
$-41.50M
1 W Prestazione:
-6.74%
1M Prestazione:
-6.74%
6M Prestazione:
-1.10%
1 anno Prestazione:
-45.26%
Intervallo 1D:
$7.16
$7.41
Intervallo di 1 settimana:
$7.16
$8.05
Portata 52W:
$3.92
$15.98
Treace Medical Concepts Inc Stock (TMCI) Company Profile
Nome
Treace Medical Concepts Inc
Settore
Industria
Telefono
(904) 373-5940
Indirizzo
100 PALMETTO PARK PLACE, PONTE VEDRA
Confronta TMCI con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TMCI
Treace Medical Concepts Inc
|
7.37 | 471.59M | 198.53M | -63.68M | -41.50M | -1.0222 |
|
ABT
Abbott Laboratories
|
112.91 | 196.55B | 41.22B | 5.77B | 6.49B | 3.29 |
|
BSX
Boston Scientific Corp
|
95.69 | 141.03B | 15.91B | 1.79B | 1.89B | 1.21 |
|
SYK
Stryker Corp
|
366.26 | 138.80B | 21.97B | 3.59B | 3.21B | 9.33 |
|
MDT
Medtronic Plc
|
81.48 | 104.60B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
73.40 | 43.28B | 6.60B | 4.16B | 490.10M | 6.93 |
Treace Medical Concepts Inc Stock (TMCI) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-31 | Iniziato | Lake Street | Buy |
| 2024-12-17 | Ripresa | JP Morgan | Neutral |
| 2024-05-16 | Downgrade | UBS | Buy → Neutral |
| 2024-05-08 | Downgrade | BTIG Research | Buy → Neutral |
| 2024-05-08 | Downgrade | JP Morgan | Overweight → Neutral |
| 2024-05-08 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2024-05-08 | Downgrade | Stifel | Buy → Hold |
| 2024-05-08 | Downgrade | Truist | Buy → Hold |
| 2023-09-29 | Iniziato | UBS | Buy |
| 2023-05-01 | Iniziato | Truist | Buy |
| 2023-04-11 | Iniziato | Stephens | Equal-Weight |
| 2022-05-12 | Iniziato | BTIG Research | Buy |
| 2022-01-07 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2021-05-18 | Iniziato | JP Morgan | Overweight |
| 2021-05-18 | Iniziato | Morgan Stanley | Equal-Weight |
| 2021-05-18 | Iniziato | SVB Leerink | Outperform |
| 2021-05-18 | Iniziato | Stifel | Buy |
Mostra tutto
Treace Medical Concepts Inc Borsa (TMCI) Ultime notizie
The Law Offices of Frank R. Cruz Continues Its Investigation of Treace Medical Concepts, Inc. (TMCI) on Behalf of Investors - Business Wire
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Position Reduced by Geode Capital Management LLC - Defense World
Barclays PLC Raises Stock Holdings in Treace Medical Concepts, Inc. (NASDAQ:TMCI) - Defense World
Insiders Of Treace Medical Concepts Are Up 58% On Their US$7.31m Purchase - Simply Wall St
Franklin Resources Inc. Acquires Shares of 36,487 Treace Medical Concepts, Inc. (NASDAQ:TMCI) - Defense World
Treace to Present at 43rd Annual J.P. Morgan Healthcare Conference - The Manila Times
Treace Medical CEO to Present at J.P. Morgan Healthcare Conference on Bunion Surgery Innovation - StockTitan
Treace Medical Concepts (NASDAQ:TMCI) Coverage Initiated by Analysts at Lake Street Capital - Defense World
Lake Street Initiates Coverage of Treace Medical Concepts (TMCI) with Buy Recommendation - MSN
This Vertex Analyst Begins Coverage On A Bullish Note; Here Are Top Initiations For Tuesday - Benzinga
Treace Medical Concepts (NASDAQ:TMCI) Now Covered by Analysts at Lake Street Capital - MarketBeat
Treace Expands Reach into High-Volume Osteotomy Market with Second MIS Osteotomy Platform, Percuplasty™ Percutaneous 3D Bunion Correction® Procedure - The Manila Times
Treace Medical Launches Groundbreaking Minimally Invasive Bunion Surgery System Targeting 450,000 Annual Procedures - StockTitan
Who Holds the Power? Discover the Forces Behind Treace Medical Concepts! - Jomfruland.net
With 54% institutional ownership, Treace Medical Concepts, Inc. (NASDAQ:TMCI) is a favorite amongst the big guns - Yahoo Finance
State Street Corp Raises Stock Holdings in Treace Medical Concepts, Inc. (NASDAQ:TMCI) - Defense World
10,003 Shares in Treace Medical Concepts, Inc. (NASDAQ:TMCI) Acquired by HighTower Advisors LLC - Defense World
Stifel Financial Corp Has $776,000 Stock Holdings in Treace Medical Concepts, Inc. (NASDAQ:TMCI) - Defense World
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Receives $7.88 Average PT from Brokerages - Defense World
Treace Medical Concepts (NASDAQ:TMCI) Stock Price Expected to Rise, Truist Financial Analyst Says - Defense World
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Shares Sold by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Defense World
Fmr LLC Purchases 54,353 Shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI) - Defense World
Treace Medical Concepts, Inc. announced that it expects to receive $2.1 million in funding - Marketscreener.com
TMCI Investors Have Opportunity to Join Treace Medical Concepts, Inc. Fraud Investigation with the Schall Law Firm - The Eastern Progress Online
Analysts Set Treace Medical Concepts, Inc. (NASDAQ:TMCI) PT at $7.88 - MarketBeat
Deep Dive Into Treace Medical Concepts Stock: Analyst Perspectives (4 Ratings) - Benzinga
Treace Medical Concepts’ (TMCI) Neutral Rating Reaffirmed at JPMorgan Chase & Co. - Defense World
Truist Financial Forecasts Strong Price Appreciation for Treace Medical Concepts (NASDAQ:TMCI) Stock - MarketBeat
Treace Medical Concepts' (TMCI) "Neutral" Rating Reaffirmed at JPMorgan Chase & Co. - MarketBeat
TMCITreace Medical Concepts, Inc. Latest Stock News & Market Updates - StockTitan
Treace Medical Concepts, Inc. Announces First Surgical Cases Utilizing SpeedPlate MicroQuad Implant - Marketscreener.com
Treace Announces First Surgical Cases Utilizing the SpeedPlate™ MicroQuad™ Implant - The Manila Times
Treace Medical Successfully Launches Revolutionary MicroQuad™ Bunion Surgery Implant - StockTitan
Reviewing AVITA Medical (NASDAQ:RCEL) and Treace Medical Concepts (NASDAQ:TMCI) - Defense World
Treace Announces First Cases Utilizing RedPoint™ Intelliguide™ Patient Specific Instrumentation with the Adductoplasty® System for Correction of Midfoot Deformities - The Manila Times
Treace Medical Launches First-Ever AI-Powered Patient-Specific Bunion Surgery System in US - StockTitan
Further Upside For Treace Medical Concepts, Inc. (NASDAQ:TMCI) Shares Could Introduce Price Risks After 84% Bounce - Simply Wall St
Treace Appoints Guy Guglielmino as Chief Commercial Officer - The Manila Times
Treace Medical Concepts, Inc. Appoints Guy Guglielmino as Chief Commercial Officer - Marketscreener.com
Brokerages Set Treace Medical Concepts, Inc. (NASDAQ:TMCI) Target Price at $7.40 - Defense World
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat
Treace Announces Participation at Stifel 2024 Healthcare Conference - The Manila Times
Treace Medical CEO to Present at Stifel 2024 Healthcare Conference | TMCI Stock News - StockTitan
Treace Medical Concepts, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
ARMISTICE CAPITAL, LLC Acquires Significant Stake in Treace Medi - GuruFocus.com
Treace Medical Concepts Reports Strong Q3 2024 Growth - TipRanks
Treace Medical Concepts Inc Azioni (TMCI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.22%
0.49%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):